andrewvanezis Profile Banner
Andrew Vanezis Profile
Andrew Vanezis

@andrewvanezis

Followers
723
Following
1K
Media
20
Statuses
390

Interventional Cardiologist #CTO, #CHIP, #CoronarySinusReducer, #INOCA, AE at #EHJCaseReports, @EdinburghUni alumni, wilderness explorer, all things 🪴🌴🌱

Nottingham, England
Joined May 2011
Don't wanna be here? Send us removal request.
@Shikha_Cardio
Shikha Jha MD, CPPS, CPHQ🫀
3 days
TCT 2025 LATE BREAKING CLINICAL TRIALS: One LINER SUMMARY 📸 AT A GLANCE ⭐️ What a phenomenal scientific meeting! Congratulations to all the presenters & leaders for their innovation, hard work and knowledge sharing. Thank you @TCTConference @TCTMD @crfheart team for a
5
75
195
@DFCapodanno
Davide Capodanno
5 days
SELUTION DeNovo met its primary endpoint of noninferiority at 1 year, with “only” 20% of DES required as bailout in the drug-coated balloon arm. Imaging use was limited in both groups, while specialty balloons were more frequently employed in the DCB+DES arm (though not
@DFCapodanno
Davide Capodanno
12 days
The most anticipated trial at next #TCT2025 is SELUTION DeNovo. So let’s take a closer look. This study represents an important crossroads for drug-coated balloons (DCBs) in de novo lesions, since—apart from small vessels—the results so far have been far from impressive. Let’s
4
31
107
@jedicath
jedicath աǟզǟʀ.ǟɦʍɛɖ
6 days
Add this to your stuck Burr algorithm! Parallel rotablator and orbital athrectomy to release a stuck burr when all else fails 🤦🏻#TCT2025
4
7
46
@NishithChandra
𝔻𝕣 ℕ𝕚𝕤𝕙𝕚𝕥𝕙 ℂ𝕙𝕒𝕟𝕕𝕣𝕒
6 days
How to retrieve a broken coronary wire “ Knuckle Twister “ technique. #TCT2025
1
4
14
@ShariqShamimMD
Dr Shariq Shamim
6 days
Interesting new CTO technique at #TCT2025 @realarainmd @SripalBangalore @evandrofilhobr
2
10
47
@DFCapodanno
Davide Capodanno
12 days
The most anticipated trial at next #TCT2025 is SELUTION DeNovo. So let’s take a closer look. This study represents an important crossroads for drug-coated balloons (DCBs) in de novo lesions, since—apart from small vessels—the results so far have been far from impressive. Let’s
7
45
159
@BCIS_uk
BCIS
2 months
Joint hosts Damien Kelly, @ALadwiniec and @andrewvanezis are representing their centres and leading delegates through a packed programme at the BCIS Interventional Trainees Course Before heading into the core and advanced stations, we’ve had talks on: 🤝Optimising individual and
2
3
12
@DrRaniKhatib
Dr Rani Khatib FESC
6 months
Introducing the CardioVascular Residual Risk Reduction (CVR³) guidelines in the UK. A game changer in addressing risk beyond LDL-C with practical strategies developed by a MDT from Yorkshire to tackle metabolic, thrombotic & inflammatory risk. Elevate the prevention game. #CVRM
3
66
188
@NUHCardioACP
NUH Cardiology ACP Team ❤️🩺
8 months
A heartfelt thank you to all our incredible speakers at the trainee ACP Study Day. Your expertise, insights, and engaging discussions truly enriched our understanding and sparked important conversations in cardiology. ❤️ #Cardiology #ACPSStudyDay
0
1
2
@Cordis_emea
Cordis International
9 months
Great momentum this week as the #Cordis UKIRE Team launched the Selution SLR DEB Academy! A fantastic programme designed to enhance our expertise in drug-eluting balloon strategies. Thank you to Dr @andrewvanezis for his expert insights on lesion preparation and PCI. #Cardiology
0
8
13
@BCIS4Trial
BCIS-4 Trial
9 months
📢Thrilled to announce that the sixth site for the BCIS-4 trial is now open at Nottingham University Hospitals NHS Trust🎉! Huge thanks to the team at Nottingham City Hospital for their rapid action in advancing this vital research. On to the next step!🚀 @andrewvanezis #BCIS4
1
2
6
@InvasiveCardiol
Journal of Invasive Cardiology
11 months
Read now: Update on the Diagnosis and Treatment of Coronary Complications of Percutaneous Coronary Interventions 👉 https://t.co/7Y0ChYBCtc @DLBHATTMD @Sant_J_Kumar @esbrilakis #cardioTwitter #cardioX #cardiology #interventionalcardiology
3
49
172
@ShaziaTHussain1
Shazia T Hussain
1 year
AICT meeting really does go from strength to strength. A great mix of educational cases,thoughtful commentary and audience discussion It was an honour for the Glenfield Hospital to be involved and certainly as operators we learnt a lot too Thankyou @ShockwaveIVL for the invite
@MillbrookMed
Millbrook Medical Conferences
1 year
Day two of Advanced Interventional Cardiovascular Therapy (AICT) offered a full schedule featuring a series of live cases from Glenfield Hospital, @LHCHFT, and St George's Hospital 🏥 #AICT #CardioEd
0
2
17
@MillbrookMed
Millbrook Medical Conferences
1 year
Day two of Advanced Interventional Cardiovascular Therapy (AICT) offered a full schedule featuring a series of live cases from Glenfield Hospital, @LHCHFT, and St George's Hospital 🏥 #AICT #CardioEd
0
3
10
@MillbrookMed
Millbrook Medical Conferences
1 year
DCB Birmingham is just one week away! Pre-register online until 12 PM on Wednesday, 13 November, or register in person on the day Earn 6 CPD credits while gaining a comprehensive overview of DCB technology, clear indications for its use, and practical insights for successful DCB
1
1
4
@CMichaelGibson
C. Michael Gibson MD
1 year
CLEAR SYNERGY trial shows no benefit with colchicine in reducing CV endpoints after MI. Download slides for CLEAR SYNERGY presented at #TCT2024 here: https://t.co/p9wwKUHXCz
10
49
137
@DrAmirKaki
Amir Kaki, MD
1 year
Today on behalf of the investigators at TCT, I was honored to present the results of the Impella ECP pivotal trial. I extend my congratulations for this major milestone in the space of MCS to all my co investigators, research teams, and sponsor Abiomed. Small bore MCS is here!
17
41
212
@MillbrookMed
Millbrook Medical Conferences
1 year
.@andrewvanezis will discuss eagerly anticipated upcoming trials and deliver one of five case presentations at #DCBBirmingham Don’t miss out—register now to join him next month: https://t.co/YeI0rjoI71 #DrugCoatedBalloons #DCB
0
2
4
@MillbrookMed
Millbrook Medical Conferences
1 year
Excited for #DCBBirmingham?🎈Check out the programme!👇 Get ready for an engaging learning experience with interactive sessions, including didactic lectures on DCB technology, its clinical applications, and case-based discussions, all led by top experts from the UK and Europe.🌍
0
1
7